Microvasculopathy in Cerebral Small Vessel Disease
- Conditions
- Cerebral small vessel disease / Ischemic stroke10007963
- Registration Number
- NL-OMON30895
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 16
Inclusion criteria cerebral large vessel disease group
TIA or stroke patients with one of the following:
-clinically demonstrated loss of sensibility
-clinically demonstrated loss of motor function;and including one or more of the following:
-hemianopsia
-aphasia
-neglect;and a carotid stenosis of more than 70% at the ipsilateral side.
Inclusion criteria cerebral small vessel disease group
Patients with a clinically established lacunar syndrome (see appendix A) and lacunar infarcts and/or leukoaraiosis on CT.
Exclusion criteria for both groups are:
-Age of less than 18 years
-Incapacitated subjects
-A Modified Rankin Scale (MRS) >3
-Diabetes Mellitus type I and II
-Smoking
-Iodine allergy
-Hyperthyroidism
Exclusion criteria cerebral large vessel disease group
-Lacunar infarcts and/or leukoaraiosis on CT
-Indication of a cardiac source of intracranial embolism;Exclusion criteria cerebral small vessel disease group
-Carotid stenosis of more than 30%
-Intermittent claudication
-Angina pectoris
-Myocardial infarction
-Radiologically demonstrated cortical infarction
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study endpoint is the difference in endothelial microvascular<br /><br>glycocalyx thickness between patients with cerebral small vessel disease and<br /><br>patients with large vessel atherosclerosis.</p><br>
- Secondary Outcome Measures
Name Time Method <p>The presence of blood parameters related to glycocalyx destruction in patients<br /><br>with cerebral small vessel disease.<br /><br>The presence of microalbuminuria in both research groups.<br /><br>The presence of pathological changes in microvessels found in skin biopsy.</p><br>